Long-term analysis of clinical disease activity and chronic organ damage in patients with systemic lupus erythematosus;Krankheitsaktivität und chronische organschäden bei patienten mit systemischem lupus erythematosus (SLE) im langzeitverlauf

Zeitschrift fur Rheumatologie

Volumn 61, Issue 5, 2002, Pages 521-531

  Rapp, C A ^a   Berner, B ^a   Muller G A ^a   Reuss Borst, M A ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Klinik Am Kurpark   (Germany)

Author keywords

Disease activity; Long term analysis; Secondary organ damage; SLE

Indexed keywords

ANTIHYPERTENSIVE AGENT; COMPLEMENT COMPONENT C3; DOUBLE STRANDED DNA; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ARTHRALGIA; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE EXACERBATION; FATIGUE; HEMATURIA; HUMAN; HYPERTENSION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MYALGIA; NEUROLOGIC DISEASE; OUTPATIENT; PRESCRIPTION; PREVALENCE; PROGNOSIS; PROTEINURIA; RASH; SKIN DEFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, ANTINUCLEAR; ANTIRHEUMATIC AGENTS; COMPLEMENT C3; DISEASE PROGRESSION; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STEROIDS;

EID: 17044443569     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-002-0345-2     Document Type: Article

References (20)

1. Al-Attia HM (1996) Clinicolaboratory profile of 33 Arabs with systemic lupus erythematosus. Postgrad Med J 72:622-679
2. Bombardier C et al (1992) Derivation of the SLEDAI: A disease activity index for lupus patients. Arthritis Rheum 35:630-640
3. Dubois EL, Tuffanelli DL (1964) Clinical manifestations of systemic lupus erythematosus. JAMA 190:112-119
4. Galve E, Candell-Riera J, Pigrau C, Permanyer-Miralda G, Garcia-del-Castillo H, Soler-Soler J (1988) Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med 319:817-823
5. Gladman DD, Urowitz MB (1987) Morbidity in systemic lupus erythematosus. J Rheumatol 14(Suppl):223-226
6. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardiere S (1996) The development and initial validation of the systemic lupus international collaborating clinics/american college of rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363-369
7. Gladman D, Goldsmith C, Urowitz M, Bacon P, Fortin P, Ginzler E, Gordon C, Hanly J, Isenberg D, Petri M, Nived O, Snaith M, Strufelt G (2000) The systemic lupus international collaborating clinics/american college of rheumatology (SLICC/ACR) damage index for systemic lupus erythematosus international comparison. J Rheumatol 27:373-376
8. Gladman D, Urowitz M, Kagal A, Hallett D (2000) Accurately describing changes in disease activity in systemic lupus erythematosus. J Rheumatol 27:377-379
9. Grafe A, Wollina U, Tebbe B, Sprott H, Uhlemann C, Hein G (1999) Fibromyalgia in lupus erythematosus. Acta Derm Venereol 79:62-64
10. Klippel JH (1990) Systemic lupus erythematosus. Treatment-related complications superimposed on chronic disease. JAMA 263:1812-1815
11. Middleton GD, McFarlin JE, Lipsky PE (1994) The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum 37:1181-1188
12. Petri M (1995) Musculoskeletal complications of systemic lupus erythematosus in the Hopkins lupus cohort: An update. Arthritis Care Res 8:137-145
13. Petri M, Perez-Gutthann S, Spence D, Hochberg MC (1992) Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 93:513-519
14. Ramsey-Goldman R, Dunn JE, Huang CF, Dunlop D, Rairie JE, Fitzgerald S, Manzi S (1999) Frequency of fractures in women with systemic lupus erythematosus: Comparison with united States population data. Arthritis Rheum 42(5):882-890
15. Swaak AJG, Groenwold J, Bronsveld W (1986) Predictive value of complement profiles and anti-ds-DNA in systemic lupus erythematosus. Ann Rheum Dis 45:359-366
16. Swaak AJG, Nossent JC, Bronsveld W, van Rooyen A, Nieuwenhuys EJ, Theuns L, Smeenk RJT (1989) Systemic lupus eyrthematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 48:447-454
17. Swaak AJ, van Den Brink HG, Smeenk RJ, Manger K, Kalden JR, Tosi S, Marchesoni A, Domljan Z, Rozman B, Logar D, Pokorny G, Kovacs L, Kovacs A, Vlachoyiannopoulos PG, Moutsopoulos HM, Chwalinska-Sadowska H, Dratwianka B, Kiss E, Cikes N, Branimir A, Schneider M, Fischer R, Bombardieri S, Mosca M, Graninger W, Smolen JS (1999) Systemic lupus erythematosus: Clinical features in patients with a disease duration of over 10 years, first evaluation. Rheumatol 38:953-958
18. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
19. Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, Ascanio AD, Bombardieri S (1992) Disease activity in systemic lupus erythematosus: Report of the consensus study group of the European workshop for rheumatology research. I. A descriptive analysis of 704 European lupus patients. Clin Exp Rheumatol 10:527-539
20. Wang B, Gladman DD, Urowitz MB (1998) Fatigue in lupus is not correlated with disease activity. J Rheumatol 25:892-895